Stock Events

Stock Events

Search...

Ocumetics Technology

€0.2

5

-€0.01-2.86% Wednesday 07:08

Statistics

Day High

0.2

Day Low

0.2

52W High

-

52W Low

-

Volume

0

Avg. Volume

-

Mkt Cap

27.68M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

30SepExpected

Q3 2021

Q4 2021

Q1 2022

Q2 2022

-0

-0

-0

-0

Expected EPS

N/A

Actual EPS

-0.0035

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2QB0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Johnson & Johnson

Johnson & Johnson, through its subsidiary Johnson & Johnson Vision Care, competes in the eye health sector, offering products that could rival Ocumetics' vision correction technologies.

Novartis, owning Alcon, competes directly in the eye care industry, providing surgical, vision care, and ophthalmic products that could be alternatives to Ocumetics' offerings.

Cooper Companies

The Cooper Companies operate through CooperVision, which manufactures contact lenses, a direct competitor to any vision correction solutions provided by Ocumetics.

Bausch Health Companies

Bausch Health Companies, through its division Bausch + Lomb, is a key player in eye health, offering products that compete across the spectrum of eye care, including surgical instruments and vision correction.

STAAR Surgical specializes in implantable lenses, directly competing with Ocumetics' potential market in innovative vision correction technologies.

National Vision

National Vision Holdings, Inc. operates a chain of vision care centers across the U.S., offering eyewear and contact lenses, competing in the broader vision correction market.

Luxottica, part of EssilorLuxottica, is a leader in eyewear manufacturing and retail, competing in the vision correction market with a broad range of products that could rival Ocumetics' solutions.

About

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company provides intraocular lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada.

Show more...

CEO

Dr. Garth T. Webb

Country

CA

ISIN

CA67577H1047

WKN

000A3C15M

Listings